Tumor antigens for determining cancer therapy | Patent Number 11628209

US 11628209 B2
Application Number16229841
Publication NumberUS 20190192643 A1
Pendency4 years, 3 months, 29 days
Filled DateDec 21, 2018
Priority DateJul 30, 2014
Publication DateJun 27, 2019
Expiration DateJul 29, 2034
Inventor/ApplicantsStefanie Hubich
Thomas Bukur
Claudia Paret
Petra Simon
Christoph Hartmann
Ugur Sahin
Kirsten Vormbrock
Christian Bender
Thorsten Litzenberger
ExaminesCOOK, LISA V
Art Unit1642
Technology Center1600
Assignments
Biontech Ag
Current
Tron Ggmbh
Original
Biontech Ag
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.